The Harvard Drug Group: Drug Recall
Recall #D-0570-2023 · 04/24/2023
Class III: Low Risk
Recall Details
- Recall Number
- D-0570-2023
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- The Harvard Drug Group
- Status
- Terminated
- Date Initiated
- 04/24/2023
- Location
- La Vergne, TN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3984 cartons
Reason for Recall
Product mixup: one foreign tablet found in product.
Product Description
Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61
Distribution Pattern
USA Nationwide
Other Recalls by The Harvard Drug Group
- Class II: Risk 06/16/2023
- Class II: Risk 02/23/2023
- Class II: Risk 02/28/2022
- Class II: Risk 02/24/2022
- Class II: Risk 08/06/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.